Archer-Daniels-Midland Company Revenue & Financials

Archer-Daniels-Midland generated exactly $87.01 billion in net sales for the fiscal year ended December 31, 2024, representing a 14.3 percent decrease from the $101.56 billion reported in FY2023, a reflection of the severe normalization of global commodity prices and the deflation of agricultural inflation following the peak of the 2022 Black Sea supply shock. This top-line contraction was driven by a massive decline in the average selling price of soybeans, corn, and wheat, combined with the compression of global freight rates and the stabilization of basis spreads across the US Midwest and the Black Sea region, which created substantial translation headwinds that obscured the company's underlying physical volume resilience. Despite the top-line pressure, the company's profitability remained exceptionally robust, achieving an operating profit of $2.95 billion and maintaining a disciplined cost structure, a testament to the company's relentless focus on operational efficiency, derivative optimization, and the strategic expansion of the high-margin Nutrition segment. This massive margin preservation was primarily driven by a favorable shift in portfolio mix toward specialty nutritional ingredients, which command significantly higher gross margins than the company's core bulk commodity and biofuel categories, combined with aggressive productivity initiatives that reduced global overhead and optimized the biological processing yields across the corn wet milling and soybean crushing networks. Gross profit expanded in the Nutrition segment, reflecting the company's ability to pass on inflationary cost increases to global food manufacturers without destroying demand, a capability that demonstrates the inelastic nature of demand for its core technical ingredients and the deep integration ADM maintains with the world's largest consumer brands. SG&A expenses as a percentage of net sales were tightly managed, reflecting the company's zero-based budgeting approach and the inherent scale efficiencies of its global logistics and distribution networks. The company's operating cash flow reached $3.1 billion, allowing it to aggressively fund its capital expenditure program for nutritional facility expansions and biological processing upgrades while simultaneously executing massive share repurchase programs and maintaining a highly attractive dividend yield. Adjusted earnings per share (EPS) reached $4.85, demonstrating the massive cash-generating potential of the business model when operating at scale, and proving that the pure-play agricultural and nutritional model is highly profitable when managed with strict operational discipline and a focus on portfolio premiumization. The company's balance sheet is highly stabilized, with management successfully maintaining a strong investment-grade credit rating, extending the duration of its liabilities, and maintaining a massive revolving credit facility to fund strategic acquisitions during periods of industry consolidation. This financial stability has been recognized by the market, driving ADM's market capitalization to over $28.5 billion by mid-2026, reflecting investor confidence in the company's proven ability to generate massive free cash flow and its dominant position in the global agricultural and nutritional sector. The company's ability to generate massive free cash flow while continuing to invest in alternative protein platforms and biological processing expansions proves that the agricultural model is highly resilient and capable of delivering sustained, long-term value creation, positioning ADM to continue taking market share from bulk commodity competitors for the foreseeable future, as global food manufacturers increasingly demand the high-quality, sustainable, and technically advanced ingredient solutions that ADM has perfected.